CC100: Phase 1 Multiple-Dose Safety and Tolerability in Subjects With ALS

Clinical trial NCT03049046 · UNKNOWN

Trial details

NCT number: NCT03049046
Sponsor: Chemigen, LLC
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2017-04-07
Primary completion: 2018-01-30
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.